Key statistics
On Wednesday, Moleculin Biotech Inc (MBRX:NAQ) closed at 2.55, 20.57% above the 52 week low of 2.12 set on Aug 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.50 |
---|---|
High | 2.63 |
Low | 2.49 |
Bid | 2.30 |
Offer | 2.63 |
Previous close | 2.50 |
Average volume | 24.21k |
---|---|
Shares outstanding | 2.84m |
Free float | 2.74m |
P/E (TTM) | -- |
Market cap | 7.11m USD |
EPS (TTM) | -11.62 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 20:59 BST.
More ▼
Press releases
- Moleculin to Host Virtual Acute Myeloid Leukemia KOL Event on October 14, 2024
- Moleculin to Present at Two Upcoming Investor Conferences
- Moleculin Announces Positive In Vivo Efficacy Data of Annamycin in Orthotopic and Experimental Lung Metastatic Models of Sarcoma
- Moleculin Participates in Virtual Investor "What this Means" Segment
- Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma
- Moleculin to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
- Moleculin Announces Closing of up to $16.5 Million Public Offering
- Moleculin Announces Pricing of up to $16.5 Million Public Offering
- Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update
More ▼